Tauriga Sciences Inc  

(Public, OTCMKTS:TAUG)   Watch this stock  
Find more results for Stella Lawrence�
0.0365
-0.0015 (-3.95%)
Jul 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.03 - 0.04
52 week 0.00 - 0.11
Open 0.04
Vol / Avg. 3.16M/8.29M
Mkt cap 25.84M
P/E     -
Div/yield     -
EPS -0.03
Shares 707.86M
Beta -1.82
Inst. own 1%

Key stats and ratios

Q1 (Mar '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -749.33% -597.21%
Return on average equity -6708.44% -
Employees 3 -
CDP Score - -

Address

39 Old Ridgebury Road
DANBURY, CT 06180
United States - Map
+1-917-7969926 (Phone)
+1-514-8403698 (Fax)

Website links

Description

Tauriga Sciences, Inc., formerly Immunovative, Inc., is a development-stage company. The Company along with Constellation Diagnostics, Inc. (Constellation) focuses on establishing a joint venture partnership to develop and commercialize a imaging-based diagnostic technology for use in predictive and preventative oncology. In July 2014, the Company acquired California-based medicinal cannabis firm Honeywood LLC.

Officers and directors

Stella M. Sung Ph.D. Chairman of the Board, Chief Executive Officer, Interim Chief Financial Officer
Age: 47
Lawrence A. May M.D. Chief Medical Officer
Age: 65
Michael Wolff Director
Age: 67
David L. Wolitzky Independent Director
Age: 76